Direkt zum Inhalt
Merck

Interactions of volatile anaesthetics with rocuronium bromide in perspective.

European journal of anaesthesiology. Supplement (1994-01-01)
S Agoston
ZUSAMMENFASSUNG

A review of several publications shows that there is general agreement that inhalational anaesthetic agents potentiate the neuromuscular effects of rocuronium in the same order as other similar agents, namely; enflurane and isoflurane > halothane > intravenous anaesthetics. However, such potentiation is not evident during induction and only becomes significant as anaesthesia becomes more prolonged. It is manifest as a prolongation in the duration of action of maintenance doses and a decrease in the recovery rate. During long-lasting procedures in which enflurane or isoflurane are used, smaller than usual maintenance doses or lower infusion rates should be employed.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Rocuronium für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Rocuronium -bromid, ≥97% (perchloric acid titration)
Rocuronium -bromid, European Pharmacopoeia (EP) Reference Standard